We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$23.3B
AUM Growth
-$265M
Cap. Flow
-$917M
Cap. Flow %
-3.93%
Top 10 Hldgs %
47.97%
Holding
197
New
23
Increased
32
Reduced
40
Closed
30

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$386M
2
AON icon
Aon
AON
+$368M
3
CTLT
CATALENT, INC.
CTLT
+$282M
4
CRM icon
Salesforce
CRM
+$266M
5
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$184M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$924M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$262M
3
CSGP icon
CoStar Group
CSGP
+$251M
4
INSP icon
Inspire Medical Systems
INSP
+$135M
5
WAB icon
Wabtec
WAB
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 29.33%
2 Technology 12.47%
3 Financials 9.64%
4 Industrials 5.44%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMNM icon
176
Immunome
IMNM
$3.24B
– –
-594,000
Closed -$14.7M
INSP icon
177
Inspire Medical Systems
INSP
$1.8B
– –
-626,854
Closed -$135M
PRAX icon
178
Praxis Precision Medicines
PRAX
$10.5B
– –
-50,000
Closed -$3.05M
SLNO
179
DELISTED
Soleno Therapeutics
SLNO
– –
-27,750
Closed -$1.19M
SWTX
180
DELISTED
SpringWorks Therapeutics
SWTX
– –
-5,000
Closed -$246K
VSTEW
181
DELISTED
Vast Renewables Limited Warrants
VSTEW
– –
-450,000
Closed -$31.5K
VSTS icon
182
Vestis
VSTS
$1.68B
– –
-4,914,753
Closed -$94.7M
XBI icon
183
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.2B
– –
-500,000
Closed -$47.4M
AVBP icon
184
ArriVent BioPharma
AVBP
$1.44B
– –
-151,768
Closed -$2.71M
ITCI
185
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-231,000
Closed -$16M
MTAL.WS
186
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
– –
-825,000
Closed -$1.75M
ALPN
187
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-5,900
Closed -$234K
SCRM
188
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
– –
-1,000,000
Closed -$10.7M
SCRMW
189
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
– –
-333,330
Closed -$157K
PXD
190
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-3,520,000
Closed -$924M
LGVCW
191
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
– –
-200,000
Closed -$20K
AEON.WS
192
DELISTED
AEON Biopharma Inc
AEON.WS
– –
-49,995
Closed -$72.5K
MVLAW
193
DELISTED
Movella Holdings Inc. Warrant
MVLAW
– –
-150,000
Closed -$945
CZOO
194
DELISTED
Cazoo Group Ltd
CZOO
– –
-714,240
Closed -$8.57M
4 5 6 7
8

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2024 Portfolio in Review

As of Q2 2024, Thomas Steyer held 197 positions worth $23.3B, down 1.1% from $23.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Thomas Steyer withdrew a net $917M in Q2 2024, closing 30 positions and reducing 40 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $924M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Walt Disney worth $356M.

  • Thomas Steyer's largest Q2 2024 buy was Walt Disney: 3,582,168 shares worth $356M.
  • Thomas Steyer added most to Aon in Q2 2024, an estimated $368M increase.
  • Thomas Steyer's biggest Q2 2024 reduction was Alphabet (Google) Class C, cutting an estimated $262M.
  • Thomas Steyer fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $924M.
  • Thomas Steyer's ten largest holdings make up 48% of its $23.3B portfolio in Q2 2024.
  • Thomas Steyer opened 23 new positions and closed 30 in Q2 2024.
  • Thomas Steyer's portfolio value fell 1.1% quarter-over-quarter to $23.3B.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.